CAT# | CPM-1-0213 |
Sequence | TLNAWVKVV |
Size | 50 Test, 100 Test | Antigen | Virus | Epitope Origin | HIV gag19-27 | MHC Restriction | HLA-A_02_01 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0196 | Mamu-A_90120-5 SIV gag tetramer-SSVDEQIQW-PE labeled | Inquiry | ||
CPM-1-0117 | HLA-A_02_01 MAGE-A1 tetramer-KVLEYVIKV-PE labeled | Inquiry | ||
CPM-1-0502 | H-2Db LCMV gp276-286 tetramer-SGVENPGGYCL-PE labeled | Inquiry | ||
CPM-1-0708 | HLA-A_02_01 EBV BRLF1 YVL tetramer-YVLDHLIVV-PE labeled | Inquiry | ||
CPM-1-0164 | HLA-A_02_01 PSA tetramer-KLQCVDLHV-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Zonisamide, sold as brand name Zonegran, is a derivative of 3-(sulfamoylmethyl)-l,2-benzisoxazole. It is a membe ...
The peptide neuroprotectant Tat-NR2B9c, also known as NA-1, is a Tat peptide consisting of the nine C-terminal ...
The peptide Difopein, designed, isolated and identified by Haian Fu, is a high affinity inhibitor of 14-3-3 pro ...
Ramoplanin is a new kind of glycopeptide antibiotics, which can inhibit the biosynthesis of the cell walls of gr ...
What is abaloparatide? Abaloparatide (formerly known as BA058) is an investigational analog of human PTHrP (1-34) being devel ...